| A Systematic Study of Retinal Structure and Function in Diabetic Macular Oedema (NCT02876393) | Queen's University, Belfast | 2014-11-01 |
| Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular ("Wet") Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME) (NCT01997164) | Regeneron Pharmaceuticals | 2014-11-01 |
| Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema (NCT02348918) | Allegro Ophthalmics, LLC | 2014-10-13 |
| A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients (NCT02359526) | Association for Innovation and Biomedical Research on Light and Image | 2014-10-01 |
| A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME) (NCT02103283) | Amgen | 2014-10-01 |
| Intravitreal Injections of Ziv-aflibercept for Macular Diseases (NCT02556723) | Retina Clinic, Sao Paulo, Brazil | 2014-09-01 |
| Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular Edema (NCT02979665) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2014-09-01 |
| Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema. (NCT02121197) | Association for Innovation and Biomedical Research on Light and Image | 2014-08-01 |
| A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME (NCT02193113) | KalVista Pharmaceuticals, Ltd. | 2014-07-18 |
| Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing) (NCT02194634) | Chengdu Kanghong Biotech Co., Ltd. | 2014-07-01 |
| Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema (NCT02245516) | Kala Pharmaceuticals, Inc. | 2014-07-01 |
| Safety and Efficacy of Ranibizumab for Diabetic Macular Edema (NCT01982435) | Justis Ehlers | 2014-06-24 |
| Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema (NCT02059772) | GWT-TUD GmbH | 2014-04-30 |
| OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits (NCT01875783) | Joslin Diabetes Center | 2014-03-17 |
| Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema (NCT02055911) | Federal University of São Paulo | 2014-03-01 |
| Phase II Combination Steroid and Anti-VEGF for Persistent DME (NCT01945866) | Jaeb Center for Health Research | 2014-02-01 |
| Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema (NCT02036424) | Raj K. Maturi, MD | 2014-01-01 |
| Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES) (NCT01947881) | Association for Innovation and Biomedical Research on Light and Image | 2014-01-01 |
| Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection (NCT02933905) | Fundació Institut Germans Trias i Pujol | 2014-01-01 |
| Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular Edema (NCT02227745) | Hospital Juarez de Mexico | 2014-01-01 |
| A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema (NCT01934556) | Palmetto Retina Center, LLC | 2013-11-01 |
| Time to Treatment Utilizing a Tele-Retinal Referral System for wAMD and DME: A Pilot Study (NCT01899963) | McMaster University | 2013-11-01 |
| Diabetic Macular Edema Treated With Ozurdex (DMEO) (NCT01951066) | Johns Hopkins University | 2013-10-01 |
| Treatment for CI-DME in Eyes With Very Good VA Study (NCT01909791) | Jaeb Center for Health Research | 2013-10-01 |
| Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab (NCT02000102) | Stanford University | 2013-09-01 |
| Comparison Between Treatment With Yellow Micropulse Laser and Green Conventional Laser in Diabetic Macular Edema (NCT01928654) | Luigi Sacco University Hospital | 2013-07-01 |
| Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema (NCT01787669) | University of Sydney | 2013-06-01 |
| Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema (NCT02096874) | King Khaled Eye Specialist Hospital | 2013-06-01 |
| Pilot Study of OCT Versus Fluorescein Angiography in DME (NCT01876914) | Oregon Health and Science University | 2013-06-01 |
| Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study (NCT01728883) | Vital Art and Science Incorporated | 2013-04-01 |
| Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab (NCT01845844) | Southeast Retina Center, Georgia | 2013-04-01 |
| Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases (NCT01975103) | Federal University of Rio Grande do Sul | 2013-03-01 |
| Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg Dexamethasone (NCT01892163) | Moorfields Eye Hospital NHS Foundation Trust | 2013-03-01 |
| A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema. (NCT01821677) | Ampio Pharmaceuticals. Inc. | 2013-02-26 |
| Safety and Effectiveness of Ozurdex Steroid Implants for DME After Vitrectomy Surgery (NCT01788475) | Lahey Clinic | 2013-02-22 |
| Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography (NCT01790945) | Retina Institute of Hawaii | 2013-02-01 |
| Comparison of Initial Treatment in With Laser Grid in Diabetic Macular Edema to Intra Vitreal Avastin Injections (NCT01769599) | Ziv Hospital | 2013-01-01 |
| Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema (NCT01823081) | Shahid Beheshti University of Medical Sciences | 2013-01-01 |
| Reading Center - Occurence of Diabetic Macular Edema in Patients With Diabetes Mellitus in Slovak Republic (NCT02063321) | Emil Martinka | 2012-12-01 |
| The Effect of Intravitreal Ozurdex on DME After Cataract Surgery (NCT01748487) | University Health Network, Toronto | 2012-12-01 |
| Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular Edema (NCT02088229) | University of Michigan | 2012-09-01 |
| Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye (NCT01661946) | Queen's University | 2012-08-01 |
| Topcon Endpoint Management (NCT01732614) | Retinal Consultants of Arizona | 2012-08-01 |
| Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema (NCT01627249) | Jaeb Center for Health Research | 2012-08-01 |
| Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study) (NCT01613716) | The Cleveland Clinic | 2012-07-01 |
| Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival (NCT01640171) | Retina Vitreous Associates of Florida | 2012-07-01 |
| Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME) (NCT01635790) | Prof. dr. R.O. Schlingemann | 2012-06-01 |
| Ranibizumab and Bevacizumab for Diabetic Macular Edema (NCT01610557) | National Eye Institute (NEI) | 2012-05-01 |
| Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema (NCT01571232) | Retina Macula Institute | 2012-04-01 |
| Grid Laser for Diffuse Diabetic Maculopathy (NCT02555956) | Dow University of Health Sciences | 2012-04-01 |
| Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE) (NCT01552408) | David M. Brown, M.D. | 2012-03-01 |
| Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF (NCT02118831) | California Retina Consultants | 2012-03-01 |
| Topical Dexamethasone - Cyclodextrin Microparticle Eye Drops for Diabetic Macular Edema (NCT01523314) | King Saud University | 2012-03-01 |
| A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) (NCT01565148) | Johns Hopkins University | 2012-02-01 |
| PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) (NCT01445899) | Quark Pharmaceuticals | 2012-02-01 |
| Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema (NCT04018833) | Bernardete Pessoa MD | 2012-01-01 |
| Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema (NCT01698749) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2011-12-01 |
| Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy (NCT01472510) | Vitreo-Retinal Associates, PC | 2011-12-01 |
| Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration (NCT01473251) | Vitreo-Retinal Associates, Michigan | 2011-11-01 |
| Vitrectomy Retinal Oxygenation (NCT01510691) | Stefan Sacu | 2011-10-01 |
| Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional Therapies (NCT00779142) | Wake Forest University | 2011-09-01 |
| Dextromethorphan for Diabetic Macular Edema (NCT01441102) | National Eye Institute (NEI) | 2011-08-01 |
| Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy (NCT01319487) | Fovea Pharmaceuticals SA | 2011-05-01 |
| NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) (NCT01331005) | Jaeb Center for Health Research | 2011-05-01 |
| Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema (NCT01546402) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2011-05-01 |
| Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema (NCT01363440) | Regeneron Pharmaceuticals | 2011-05-01 |
| Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema (NCT01698788) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2011-05-01 |
| Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study (NCT01304706) | Alimera Sciences | 2011-04-01 |
| Ranibizumab as a Rescue Therapy for Diabetic Macular Edema (NCT01253694) | New England Retina Associates | 2011-03-01 |
| Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema (NCT01309451) | Maturi, Raj K., M.D., P.C. | 2011-03-01 |
| Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab (NCT01292798) | California Retina Consultants | 2011-03-01 |
| Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting (NCT01318941) | Novartis Pharmaceuticals | 2011-03-01 |
| Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema (NCT01189461) | Pfizer | 2011-01-01 |
| Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery (NCT01284478) | Northern California Retina Vitreous Associates | 2011-01-01 |
| Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema (NCT02002403) | Unity Health Toronto | 2011-01-01 |
| Safety Study of ALG- 1001 to Treat Diabetic Macular Edema (NCT01482871) | Allegro Ophthalmics, LLC | 2011-01-01 |
| Ranibizumab "Treat and Extend" in Diabetic Macular Edma (NCT01297569) | Novartis Pharmaceuticals | 2011-01-01 |
| Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular Edema (NCT01572350) | Hospital Universitario de Canarias | 2010-10-01 |
| Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus (NCT01171976) | Novartis Pharmaceuticals | 2010-09-01 |
| Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema (NCT01168258) | National Eye Institute (NEI) | 2010-07-07 |
| Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME) (NCT01135914) | Novartis Pharmaceuticals | 2010-07-01 |
| Blood-retinal Barrier Imaging and Neuropsychiatric Sequela in Type 2 Diabetes Mellitus (NCT01107132) | Soroka University Medical Center | 2010-05-01 |
| Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium (NCT01573572) | Bausch & Lomb Incorporated | 2010-04-22 |
| Safety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME) (NCT01324869) | Chengdu Kanghong Biotech Co., Ltd. | 2010-04-01 |
| A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema (NCT01120899) | National Eye Institute (NEI) | 2010-04-01 |
| MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2) (NCT01112085) | Especialistas en Retina Medica y Quirurgica Grupo de Investigacion | 2010-04-01 |
| Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study (NCT01077401) | Johns Hopkins University | 2010-02-01 |
| Study of MP0112 Intravitreal Injection in Patients With Diabetic Macular Edema (NCT01042678) | Allergan | 2010-02-01 |
| Glycemic Control and Diabetic Macular Edema (NCT01358396) | Cairo University | 2010-01-01 |
| A Comparison of Islet Cell Transplantation With Medical Therapy for the Treatment of Diabetic Eye Disease (NCT00853424) | University of British Columbia | 2009-12-01 |
| Micropulse 577 nm Laser Photocoagulation Versus Conventional 532 nm Laser Photocoagulation for Diabetic Macular Oedema (NCT01045239) | University of Malaya | 2009-10-01 |
| Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA) (NCT00997191) | University of Sao Paulo | 2009-10-01 |
| Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema (NCT00989989) | Novartis | 2009-09-01 |
| Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema (NCT00959725) | Icahn School of Medicine at Mount Sinai | 2009-08-01 |
| Anterior and Posterior Segment Vascular Changes Following Laser and Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Diabetic Retinopathy (NCT01196325) | University of Toronto | 2009-07-01 |
| Supplemental Adjuvants for Intracellular Nutrition and Treatment (NCT00893724) | Mid-Atlantic Retina Consultations, Inc. | 2009-06-01 |
| Evaluation of the Role of Intravitreal Tissue Plasminogen Activator in Treatment of Refractory Diabetic Macular Edema (NCT01141881) | Mashhad University of Medical Sciences | 2009-05-01 |
| Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study (NCT01486238) | Valley Retina Institute | 2009-04-01 |
| Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular Edema (NCT01342159) | Hallym University Medical Center | 2009-03-01 |
| Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study (NCT02308644) | University of Sao Paulo | 2009-02-01 |